REBECCA DAVIES: Open Payments
NPI 1548347198 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 66 payments from 13 companies in 2025. Trend: 2023 $1,309 · 2024 $991 · 2025 $1,242
Food & beverage: $1,173Education: $69
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $357 |
| Janssen Biotech, Inc. | 10 | $259 |
| ABBVIE INC. | 14 | $180 |
| Lilly USA, LLC | 5 | $100 |
| GENZYME CORPORATION | 2 | $61 |
| UCB, Inc. | 2 | $52 |
| Incyte Corporation | 2 | $49 |
| Botanix SB Inc | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
Products named: COSENTYX, TREMFYA, SKYRIZI, TALTZ, DUPIXENT, Bimzelx, OPZELURA, SOFDRA.
Industry payments across KY — which companies pay providers there.
